Evidence map›Paper›PMID 23975476›Full record

Trial reportAIDS and behavior2013

Does effective depression treatment alone reduce secondary HIV transmission risk? Equivocal findings from a randomized controlled trial.

Alexander C Tsai, Matthew J Mimiaga, James W Dilley, Gwendolyn P Hammer, Dan H Karasic, Edwin D Charlebois, James L Sorensen, Steven A Safren, David R Bangsberg

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 4 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Is the glass half full or half empty? Treatment of depression and HIV/AIDS medication adherence: a comment on Sin and DiMatteo.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

Alexander C TsaiChester M. Pierce, MD Division of Global Psychiatry, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA, actsai@partners.org.
Matthew J Mimiaga
James W Dilley
Gwendolyn P Hammer
Dan H Karasic
Edwin D Charlebois
James L Sorensen
Steven A Safren
David R Bangsberg
San Francisco General Hospital · USCalifornia Department of Public Health · USCenter for Global Health · USCommunity Health Alliance · USFenway Health · USHarvard University · USMassachusetts General Hospital · USSan Francisco AIDS Foundation · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RAJESH T GANDHI · 2004 to 2026
$94.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
Western States Node of the National Drug Abuse Treatment Clinical Trials NetworkU10DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCARTY, DENNIS, SORENSEN, JAMES L · 2002 to 2015
$25.2M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
Depression Treatment to Improve ARV Therapy AdherenceR01MH063011 · NIMH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 2001 to 2004
$2.5M
Microenterprise to empower and improve health of HIV+ women in UgandaK23MH096620 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TSAI, ALEXANDER C · 2012 to 2016
$922k
Mentoring Patient Oriented Adherence Research in UgandaK24MH087227 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BANGSBERG, DAVID ROY · 2009 to 2013
$776k
NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI060354NIAID NIH HHS P30AI060354NIDA NIH HHS U10 DA015815NIMH NIH HHS K23 MH096620NIMH NIH HHS K23MH096620NIMH NIH HHS K24 MH087227NIMH NIH HHS K24MH087227NIMH NIH HHS R01 MH054907NIMH NIH HHS R01MH054907NIMH NIH HHS R01 MH063011NIMH NIH HHS R01MH063011
6 · The paper itself

Abstract

Depressed mood has been associated with HIV transmission risk behavior. To determine whether effective depression treatment could reduce the frequency of sexual risk behavior, we analyzed secondary outcome data from a 36-week, two-arm, parallel-design, randomized controlled trial, in which homeless and marginally housed, HIV-infected persons with comorbid depressive disorders were randomized to receive either: (a) directly observed treatment with the antidepressant medication fluoxetine, or (b) referral to a local public mental health clinic. Self-reported sexual risk outcomes, which were measured at 3, 6, and 9 months, included: total number of sexual partners, unprotected sexual intercourse, unprotected sexual intercourse with an HIV-uninfected partner or a partner of unknown serostatus, and transactional sex. Estimates from generalized estimating equations regression models did not suggest consistent reductions in sexual risk behaviors resulting from treatment. Mental health interventions may need to combine depression treatment with specific skills training in order to achieve durable impacts on HIV prevention outcomes.

Indexed as

Ill-Housed PersonsSexual BehaviorAdultAntidepressive Agents, Second-GenerationComorbidityDepressionFemaleFluoxetineFollow-Up StudiesHIV InfectionsHumansMaleMiddle AgedReferral and ConsultationRisk AssessmentRisk-TakingAntidepressive Agents, Second-GenerationFluoxetine

Identifiers

PMID23975476
PMCPMC3805275
OpenAlexW2059566548

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.